CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments
CompanyDeals

CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments

Cloudbreak Pharma Files for Hong Kong IPO Amid Ophthalmic Drug Development
CompanyDeals

Cloudbreak Pharma Files for Hong Kong IPO Amid Ophthalmic Drug Development

Nona Biosciences Licenses HCAb Technology to Visterra for Biologic Development
CompanyDeals

Nona Biosciences Licenses HCAb Technology to Visterra for Biologic Development

BioNTech in Deal to Acquire CureVac for $1.25B to Boost Cancer mRNA Therapies
CompanyDeals

BioNTech in Deal to Acquire CureVac for $1.25B to Boost Cancer mRNA Therapies

AbbVie's Mavyret Gains FDA Approval for Acute HCV in Children and Adults
CompanyDrug

AbbVie’s Mavyret Gains FDA Approval for Acute HCV in Children and Adults

Zhaoke Ophthalmology's TAB014 Receives BLA Review for wAMD Treatment
CompanyDrug

Zhaoke Ophthalmology’s TAB014 Receives BLA Review for wAMD Treatment

GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries
CompanyDeals

GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries

MSD Launches Phase III Trial for Quadrivalent Dengue Vaccine V181
CompanyDrug

Merck Launches Phase III Trial for Quadrivalent Dengue Vaccine V181

NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery
CompanyDeals

NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery

Sanofi's Rilzabrutinib Shows Promise in IgG4-Related Disease Trial
CompanyDrug

Sanofi’s Rilzabrutinib Shows Promise in IgG4-Related Disease Trial

Bayer Extends Genomics Partnership With Broad Institute for Cardiology Research
CompanyDeals

Bayer Extends Genomics Partnership With Broad Institute for Cardiology Research

Bayzed Health Launches HK IPO to Expand Cancer Care Services
CompanyDeals

Bayzed Health Launches HK IPO to Expand Cancer Care Services